Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
16 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
Charles Perou Receives 2013 Battle Cancer Research Award
by William Shawn Davis published May 24, 2013 last modified May 24, 2013 04:04 PM — filed under:
Charles Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology, has been honored with the 2013 Hyman L. Battle Distinguished Cancer Research Award in recognition of his accomplishments in cancer research. Dr. Perou is a member of UNC Lineberger Comprehensive Cancer Center.
Located in News
Factors Influencing Delay in Breast Cancer Treatment Differ For African-American and White Women
by William Shawn Davis (wishda) published Jul 09, 2013 last modified Jul 10, 2013 08:55 AM — filed under:
Different factors influence delay between diagnosis and first course of treatment for breast cancer for African-American and White women.
Located in News
Four UNC nursing graduate students awarded American Cancer Society scholarships
by William Shawn Davis (wishda) published Jun 10, 2013 — filed under:
Four UNC School of Nursing students have been awarded American Cancer Society Graduate Scholarships in Cancer Nursing Practice. The recipients are Sean Gallagher, RN; April Lenker, RN; Melissa Matson, RN; and Lori Walker, RN.
Located in News
Human and canine lymphomas share molecular similarities, first large-scale comparison shows
by William Shawn Davis (wishda) published Jun 25, 2013 last modified Jun 26, 2013 09:07 AM — filed under:
Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it’s the most common lymphoma subtype while in dogs, it’s one of the most common cancers in veterinary oncology.
Located in News
Lymphedema therapy provides relief for cancer patients
by Dianne Shaw published Mar 25, 2013 last modified Apr 12, 2013 04:07 PM — filed under:
“It’s a lifesaver.” That’s how Frances Patterson, a breast cancer patient, describes the therapy she receives for lymphedema through the UNC Comprehensive Cancer Support Program.
Located in News
Murine study predicts cancer drug responsiveness in human tumors
by William Shawn Davis (wishda) published Jul 01, 2013 last modified Jul 03, 2013 05:13 PM — filed under:
It’s a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Located in News
Murine study predicts cancer drug responsiveness in human tumors
by William Shawn Davis (wishda) published Jul 01, 2013 last modified Jul 01, 2013 10:31 AM — filed under:
It’s a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Located in Old top news stories
NCI Provocative Questions grants awarded to three at UNC Lineberger
by William Shawn Davis (wishda) published Aug 20, 2013 last modified Aug 20, 2013 08:51 AM — filed under:
UNC Lineberger scientists Blossom Damania, PhD, Dirk Dittmer, PhD, and Liza Makowski, PhD, have been awarded two-year National Cancer Institute Provocative Questions grants.
Located in News
New study shows on balance that prostate cancer prevention drug appears to provide benefit
by William Shawn Davis (wishda) published Aug 19, 2013 — filed under:
A team of researchers has published their analysis of survival rates among study participants in the 2003 Prostate Cancer Prevention Trial showing that the prostate drug finasteride does not decrease survival after a diagnosis of prostate cancer. Their 2003 publication found that while the drug finasteride significantly reduced the risk of prostate cancer, it was associated with an increased risk of high-grade disease and possibly decreased survival.
Located in News
Ollila appointed James H. and Jesse E. Millis Distinguished Professor
by Dianne Shaw published Aug 26, 2013 — filed under:
David Ollila, MD, professor of surgery, has been appointed to the James H. and Jesse E. Millis Distinguished Professorship. The $1.5 million professorship was established by their son, William (Bill) Millis in honor of his parents, Jim and Jesse Millis of High Point, N.C.
Located in News